AKT1 and colorectal cancer: Compensatory activation of AKT downstream targets (including mTORC1 in breast and colorectal cancer cell lines) by SGK1 has been observed in response to AKT blockade, suggesting that SGKs may mediate AKT-driven tumorigenic processes in the presence of an AKT inhibitor [258,261,262,263].